Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular energy-sensing pathways are integrated biochemical circuits that monitor nutrient availability and cellular energy status, primarily ATP levels, to maintain metabolic homeostasis (Hardie, 2011, Genes & Dev). The primary components of this network include AMP-activated protein kinase (AMPK), which acts as a fuel gauge by sensing the AMP:ATP ratio, and the mechanistic target of rapamycin (mTOR), which coordinates cell growth and protein synthesis with nutrient availability (Saxton & Sabatini, 2017, Cell). Other critical sensors include Sirtuins, which respond to NAD+ levels, and Hypoxia-inducible factors (HIF), which sense oxygen availability (Cantó & Auwerx, 2009, Curr Opin Lipidol). These pathways are frequently dysregulated in metabolic disorders like type 2 diabetes and obesity, and they are often hijacked by cancer cells to support rapid proliferation and survival under nutrient-poor conditions (Gonzalez et al., 2020, Cell Metabolism). Pharmacological intervention typically involves using AMPK activators like metformin to improve insulin sensitivity or mTOR inhibitors like rapamycin to treat cancer and prevent transplant rejection (Zhang et al., 2017, Nature Reviews Molecular Cell Biology). However, because these pathways are fundamental to nearly all cellular processes, achieving tissue-specific targeting and avoiding systemic toxicities such as immunosuppression or metabolic imbalance remains a significant therapeutic challenge.
Modulation of key metabolic regulators, such as the activation of AMP-activated protein kinase (AMPK) or the inhibition of mechanistic target of rapamycin (mTOR), to shift cellular metabolism from anabolic to catabolic states or vice versa based on energy availability (Hardie, 2011, Genes & Dev).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular energy-sensing pathways.